Cargando…

Empagliflozin inhibits coronary microvascular dysfunction and reduces cardiac pericyte loss in db/db mice

BACKGROUND: Coronary microvascular dysfunction (CMD) is a pathophysiological feature of diabetic heart disease. However, whether sodium-glucose cotransporter 2 (SGLT2) inhibitors protect the cardiovascular system by alleviating CMD is not known. OBJECTIVE: We observed the protective effects of empag...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tu, Yimin, Li, Qing, Zhou, Yuanchen, Ye, Zixiang, Wu, Chao, Xie, Enmin, Li, Yike, Li, Peizhao, Wu, Yaxin, Guo, Ziyu, Yu, Changan, Zheng, Jingang, Gao, Yanxiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9800791/ https://www.ncbi.nlm.nih.gov/pubmed/36588571 http://dx.doi.org/10.3389/fcvm.2022.995216

Ejemplares similares

Ticagrelor vs. clopidogrel for coronary microvascular dysfunction in patients with STEMI: a meta-analysis of randomized controlled trials
por: Li, Yike, et al.
Publicado: (2023)

Predictive Value of the CHA(2)DS(2)-VASc Score for Mortality in Hospitalized Acute Coronary Syndrome Patients With Chronic Kidney Disease
por: Wu, Yaxin, et al.
Publicado: (2022)

The triglyceride glucose index is associated with future cardiovascular disease nonlinearly in middle-aged and elderly Chinese adults
por: Ye, Zixiang, et al.
Publicado: (2022)

Blood Group O Protect End-Stage Renal Disease Patients With Dialysis From Coronary Artery Disease
por: Ye, Zixiang, et al.
Publicado: (2022)

Triglyceride glucose index exacerbates the risk of future cardiovascular disease due to diabetes: evidence from the China Health and Retirement Longitudinal Survey (CHARLS)
por: Ye, Zixiang, et al.
Publicado: (2022)

Evaluating the predictive value of diabetes mellitus diagnosed according to the Chinese guidelines (2020 edition) for cardiovascular events
por: Ye, Zixiang, et al.
Publicado: (2022)

Canada acute coronary syndrome risk score predicts no-/slow-reflow in ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention
por: Xie, Enmin, et al.
Publicado: (2023)

Cardioprotective effects of short-term empagliflozin treatment in db/db mice
por: Radlinger, Bernhard, et al.
Publicado: (2020)

Predictive value of the stress hyperglycemia ratio in dialysis patients with acute coronary syndrome: insights from a multi-center observational study
por: Xie, Enmin, et al.
Publicado: (2023)

The triglyceride-glucose index predicts 1-year major adverse cardiovascular events in end-stage renal disease patients with coronary artery disease
por: Xie, Enmin, et al.
Publicado: (2023)

Design and rationale of the ATTRACTIVE trial: a randomised trial of intrAThrombus Thrombolysis versus aspiRAtion thrombeCTomy during prImary percutaneous coronary interVEntion in ST-segment elevation myocardial infarction patients with high thrombus burden
por: Zhang, Zhen, et al.
Publicado: (2023)

Empagliflozin alleviates podocytopathy and enhances glomerular nephrin expression in db/db diabetic mice
por: Klimontov, Vadim V, et al.
Publicado: (2020)

Association of triglyceride–glucose index with coronary severity and mortality in patients on dialysis with coronary artery disease
por: Xie, Enmin, et al.
Publicado: (2023)

Effects of Metformin on COVID-19 Patients with Type 2 Diabetes: A Retrospective Study
por: Guo, Ziyu, et al.
Publicado: (2023)

Association between the triglyceride glucose index and in-hospital and 1-year mortality in patients with chronic kidney disease and coronary artery disease in the intensive care unit
por: Ye, Zixiang, et al.
Publicado: (2023)

S-Propargyl-Cysteine Attenuates Diabetic Cardiomyopathy in db/db Mice Through Activation of Cardiac Insulin Receptor Signaling
por: Li, Ye, et al.
Publicado: (2021)

Growth hormone-releasing hormone agonist attenuates vascular calcification in diabetic db/db mice
por: Ren, Hao-Lin, et al.
Publicado: (2023)

Empagliflozin Ameliorates Type 2 Diabetes-Induced Ultrastructural Remodeling of the Neurovascular Unit and Neuroglia in the Female db/db Mouse
por: Hayden, Melvin R., et al.
Publicado: (2019)

Early combination therapy of empagliflozin and linagliptin exerts beneficial effects on pancreatic β cells in diabetic db/db mice
por: Fushimi, Yoshiro, et al.
Publicado: (2021)

The prediction of in-hospital mortality in chronic kidney disease patients with coronary artery disease using machine learning models
por: Ye, Zixiang, et al.
Publicado: (2023)

Valsartan alleviates the blood–brain barrier dysfunction in db/db diabetic mice
por: Cai, Longxue, et al.
Publicado: (2021)

Impact of Syndecan-2-Selected Mesenchymal Stromal Cells on the Early Onset of Diabetic Cardiomyopathy in Diabetic db/db Mice
por: Pappritz, Kathleen, et al.
Publicado: (2021)

Redox Signaling and Regional Heterogeneity of Endothelial Dysfunction in db/db Mice
por: Sallam, Nada A., et al.
Publicado: (2020)

Single-Cell Sequencing Analysis of the db/db Mouse Hippocampus Reveals Cell-Type-Specific Insights Into the Pathobiology of Diabetes-Associated Cognitive Dysfunction
por: Ma, Shizhan, et al.
Publicado: (2022)

Once daily administration of the SGLT2 inhibitor, empagliflozin, attenuates markers of renal fibrosis without improving albuminuria in diabetic db/db mice
por: Gallo, Linda A., et al.
Publicado: (2016)

Shengmai San Ameliorates Myocardial Dysfunction and Fibrosis in Diabetic db/db Mice
por: Zhao, Juan, et al.
Publicado: (2016)

Inhibition of acid sphingomyelinase activity ameliorates endothelial dysfunction in db/db mice
por: Jiang, Meng, et al.
Publicado: (2019)

Cosmos DB for MongoDB developers: migrating to Azure Cosmos DB and using the MongoDB API
por: Sharma, Manish
Publicado: (2018)

Erratum: Once daily administration of the SGLT2 inhibitor, empagliflozin, attenuates markers of renal fibrosis without improving albuminuria in diabetic db/db mice
por: Gallo, Linda A., et al.
Publicado: (2016)

SGLT2 Inhibitor Empagliflozin and DPP4 Inhibitor Linagliptin Reactivate Glomerular Autophagy in db/db Mice, a Model of Type 2 Diabetes
por: Korbut, Anton I., et al.
Publicado: (2020)

Shensong Yangxin Capsule Reduces the Susceptibility of Arrhythmia in db/db Mice via Inhibiting the Inflammatory Response Induced by Endothelium Dysfunction
por: Zhang, Jiehan, et al.
Publicado: (2023)

Anti-diabetic activities of catalpol in db/db mice
por: Bao, Qinwen, et al.
Publicado: (2016)

Gut Microbiota Composition and Structure of the Ob/Ob and Db/Db Mice
por: Yang, Mingsheng, et al.
Publicado: (2019)

Portulaca oleracea Ameliorates Diabetic Vascular Inflammation and Endothelial Dysfunction in db/db Mice
por: Lee, An Sook, et al.
Publicado: (2012)

Effect of Astragalus Polysaccharides on Cardiac Dysfunction in db/db Mice with Respect to Oxidant Stress
por: Chen, Wei, et al.
Publicado: (2018)

Endothelial Dysfunction and Passive Changes in the Aorta and Coronary Arteries of Diabetic db/db Mice
por: Beck, Lilliana, et al.
Publicado: (2020)

Retinal Neurodegeneration in db/db Mice at the Early Period of Diabetes
por: Yang, Qin, et al.
Publicado: (2015)

Hyperglycemia promotes myocardial dysfunction via the ERS-MAPK10 signaling pathway in db/db mice
por: Deng, Ya-Wen, et al.
Publicado: (2022)

Antidiabetic and Antiobesity Effects of Artemether in db/db Mice
por: Guo, Yu, et al.
Publicado: (2018)

Protective effect of carvacrol on liver injury in type 2 diabetic db/db mice
por: Zhao, Wei, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_16ubed6l5sg5jng8qqdtjb9f8f